Filing Details

Accession Number:
0001209191-17-051978
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-07 20:17:10
Reporting Period:
2017-09-05
Accepted Time:
2017-09-07 20:17:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1533040 Rxi Pharmaceuticals Corp RXII Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1694380 Alexey Eliseev C/O 257 Simarano Drive, Suite 101
Marlborough MA 01752
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Disposition 2017-09-05 26,181 $0.56 1,100,931 No 4 S Direct
Common Stock, Par Value $0.0001 Disposition 2017-09-06 91,907 $0.54 1,009,024 No 4 S Direct
Common Stock, Par Value $0.0001 Disposition 2017-09-07 58,712 $0.53 950,312 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. Represents the weighted average sale price. The lowest price at which shares were sold was $0.55 and the highest price at which shares weresold was $0.58.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full informationregarding the number of shares and prices at which the transaction was effected.
  3. Represents the weighted average sale price. The lowest price at which shares were sold was $0.525 and the highest price at which shares weresold was $0.561.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full informationregarding the number of shares and prices at which the transaction was effected.
  4. Represents the weighted average sale price. The lowest price at which shares were sold was $0.52 and the highest price at which shares were sold was $0.545.The reporting person hereby undertakes to provide upon request to the SEC staff or other appropriate persons full information regarding the number of shares and prices at which the transaction was effected.